Physician profile
Alan H Chen
NPI 1689878480
$32,735.87
in general payments reported to CMS, 2019-2025
32 companies · $7,602 in 2025
The $7,602 reported for 2025 was more than what 95% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $949 · 2021: $2,222 · 2022: $3,348 · 2023: $2,342 · 2024: $15K · 2025: $7,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,225 · Honoraria: $5,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,275 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,200 · Travel and Lodging: $1,371 · Consulting Fee: $1,120 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,225.00 |
| Honoraria | $5,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,274.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,200.00 |
| Travel and Lodging | $1,370.73 |
| Consulting Fee | $1,120.00 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $16,409.67 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Allergan, INC. | $4,218.03 | 2019-2023 | |
| Mentor Worldwide LLC | $3,925.38 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $3,446.48 | 2023-2025 | Botox |
| Intuitive Surgical, INC. | $1,000.00 | 2025 | |
| Acumed LLC | $785.87 | 2021-2025 | Acumed, Acumed, Inframe Implant |
| Musculoskeletal Transplant Foundation INC. | $578.79 | 2019-2025 | |
| Davol INC. | $419.73 | 2022-2025 | Phasix Mesh, Arista |
| Endo Pharmaceuticals INC. | $368.11 | 2019-2022 | |
| Tela Bio, INC. | $273.42 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Merz North America, INC. | $240.61 | 2019 | |
| Revance Therapeutics, INC. | $136.46 | 2025 | Daxxify |
| Innovation Technologies INC | $115.52 | 2022 | |
| Axogen | $94.23 | 2023-2025 | Avance Nerve Graft |
| Tepha INC | $87.68 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $74.53 | 2020-2022 | |
| Orthofix Medical, INC. | $68.52 | 2020-2024 | Physio-Stim |
| Acera Surgical, INC. | $57.04 | 2021-2022 | |
| Smith+Nephew, INC. | $50.96 | 2019-2025 | Stravix, Grafix, Stravix Pl |
| Checkpoint Surgical, INC | $45.99 | 2021-2024 | Checkpoint Stimulators |
| Galderma Laboratories, L.P. | $42.85 | 2021-2023 | |
| Depuy Synthes Sales INC. | $41.19 | 2025 | Microfix Quickanchor Ethibond |
| Lifenet Health | $39.58 | 2024 | Theragenesis Wound Matrix |
| Coopersurgical, INC. | $36.14 | 2019-2025 | Onetrac Lx |
| Kci USA, INC. | $35.56 | 2019-2021 | |
| Organogenesis INC. | $30.31 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $25.99 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $22.95 | 2019 | |
| Baudax Bio INC. | $19.08 | 2021 | |
| Aroa Biosurgery Incorporated | $18.95 | 2023 | |
| Sonex Health, INC. | $17.73 | 2020 | |
| Polynovo North America LLC | $8.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.